7,641
Views
35
CrossRef citations to date
0
Altmetric
Original Articles

The Modified Ketogenic Diet in Adults with Glioblastoma: An Evaluation of Feasibility and Deliverability within the National Health Service

ORCID Icon, , &
Pages 643-649 | Received 23 Jun 2017, Accepted 26 Feb 2018, Published online: 18 Apr 2018

References

  • Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, et al.: Long term survival with Glioblastoma multiforme. Brain 130, 2596–2606, 2007. doi:10.1093/brain/awm204.
  • Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, et al.: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352, 987–996, 2005. doi:10.1056/NEJMoa043330.
  • Gilbert MR, Dignam JJ, Armstrong TS, Wefel JS, Blumenthal DT, et al.: A randomized trial of Bevacizumab for newly diagnosed glioblastoma. N Engl J Med 370, 699–708, 2014. doi:10.1056/NEJMoa1308573.
  • Stupp R, Hegi ME, Gorlia T, Erridge SC, Perry J, et al.: Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071–22072 study): A multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 15, 1100–1108, 2014. doi:10.1016/S1470-2045(14)70379-1.
  • James Lind Alliance Priority Setting Partnerships: Neuro-oncology Top 10 | James Lind Alliance [Internet]. Crown Copyright, 2017. 2015 [cited 2017 Jan 10]. Available from: http://www.jla.nihr.ac.uk/priority-setting-partnerships/neuro-oncology/top-10-priorities/
  • Woolf EC, Scheck AC: The Ketogenic diet for the treatment of malignant glioma. J Lipid Res 56, 5–10, 2015. doi:10.1194/jlr.R046797.
  • Abdelwahab MG, Fenton KE, Preul MC, Rho J, Lynch A, et al.: The ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma. PLos One 7, e36197, 2012. doi:10.1371/journal.pone.0036197.
  • Allen BG, Bhatia SK, Buatti JM, Brandt K, Lindholm K, et al.: Ketogenic diets enhance oxidative stress and radiochemotherapy response in lung cancer xenografts. Clin Cancer Res 19, 3905–3913, 2013. doi:10.1158/1078-0432.CCR-12-0287.
  • Jiang YS, Wang FR: Caloric restriction reduces edema and prolongs survival in a mouse glioma model. J Neurooncol 114, 25–32, 2013. doi:10.1007/s11060-013-1154-y.
  • Nebeling LC, Miraldi F, Shurin SB, Lerner E: Effects of ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports. J Am Coll Nutr 14, 202–208, 1995. doi:10.1080/07315724.1995.10718495.
  • Kalamian M, Zupec-Kania B, Favara BE, Liepa GU: Ketogenic diet as an adjuvant therapy for brain tumors. First international symposium on the ketogenic diet for epilepsy and other neurological disorders. Barrows Neurological Institute, Phoenix, Arizona: Poster presentation, 2008.
  • Schwartz K, Chang HT, Nikolai M, Pernicone J, Rhee S, et al.: Treatment of glioma patients with ketogenic diets: report of two cases treated with an IRB-approved energy-restricted ketogenic diet protocol and review of the literature. Cancer Metab 3, 2–10, 2015. doi:10.1186/s40170-015-0129-1.
  • Zuccoli G, Marcello N, Pisanello A: Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: Case report. Nutr Metab 7, 1–7, 2010. doi:10.1186/1743-7075-7-33.
  • Rieger J, Bahr O, Maurer GD, Hattingen E, Franz K, et al.: ERGO: A pilot study of ketogenic diet in recurrent glioblastoma. Int J Oncol 44, 1843–1852, 2014. doi:10.3892/ijo.2014.2382.
  • Bergqvist AGC, Schall JI, Gallagher PR, Cnaan A, Stallings VA: Fasting versus gradual initiation of the ketogenic diet: a prospective, randomized clinical trial of efficacy. Epilepsia 46, 1810–1819, 2005. doi:10.1111/j.1528-1167.2005.00282.x.
  • Kossoff EH, McGrogan JR, Bluml RM, Pillas DJ, Rubenstein JE, Vining EP: A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy. Epilepsia 47, 421–424, 2006. doi:10.1111/j.1528-1167.2006.00438.x.
  • Kossoff EH, Turner Z, Bluml RM, Pyzik PL, Vining EPG: A randomized, crossover comparison of daily carbohydrate limits using the modified Atkins diet. Epilepsy & Behavior 10, 432–436, 2007. doi:10.1016/j.yebeh.2007.01.012.
  • Kossoff EH, Rowley H, Sinha SR, Vining EPG: A prospective study of the modified Atkins diet for intractable epilepsy in adults. Epilepsia 49, 316–319, 2008. doi:10.1111/j.1528-1167.2007.01256.x.
  • Martin K, Jackson C, Levy RG, Cooper PN: Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database of Syst Rev 2, Art No. CD001903, 2016.
  • Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, et al.: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol [Internet] 114(2), 97–109, 2007 Aug. [cited 2017 Jun 23]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/17618441. doi:10.1007/s00401-007-0243-4.
  • Strowd RE, Cervenka MC, Henry BJ, Kossoff EH, Hartman AL, et al.: Glycemic modulation in neuro-oncology: experience and future directions using a modified Atkins diet for high-grade brain tumors. Neurooncol Pract 2, 127–136, 2015.
  • Kossoff EH, Rowley H, Sinha SR, Vining EPG: A prospective study of the modified Atkins diet for intractable epilepsy in adults. Epilepsia 49, 316–319, 2008. doi:10.1111/j.1528-1167.2007.01256.x.
  • El-Rashidy OF, Nassar MF, Abde-Hamid IA, Shatla RH, Abdel-Hamid HM, et al.: Modified Atkins diet vs classic ketogenic formula in intractable epilepsy. Acta Neurol Scand 128, 402–408, 2013. doi:10.1111/ane.12137.
  • Sharma S, Sankhyan N, Gulati S, Agarwala A: Use of the modified Atkins diet for treatment of refractory childhood epilepsy: a randomized controlled trial. Epilepsia 54, 481–6, 2013. doi:10.1111/epi.12069.
  • Kwiterovich PO Jr, Vining EPG, Pyzik P, Skolasky R Jr, Freeman JM: Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children. JAMA 290, 912–920, 2003. doi:10.1001/jama.290.7.912.
  • Feillet F, Steinmann G, Vianey-Saban C, de Chillou C, Sadoul N, et al.: Adult presentation of MCAD deficiency revealed by coma and severe arrythmias. Intensive Care Med 29, 1594–1597, 2003. doi:10.1007/s00134-003-1871-3.